Trademark: 79076423
Word
CELLPROTHERA
Status Date
Thursday, August 1, 2019
Registration Number
3980163
Registration Date
Tuesday, June 21, 2011
Filing Date
Friday, July 31, 2009
Published for Opposition
Tuesday, April 5, 2011
Cancellation Date
Thursday, August 1, 2019
5 Biological preparations for cell cultures; cell culture media, namely, culture media for endothelial and myocardiac cells; culture media for cell growth for medical biotechnology, namely,culture media for growing and regenerating endothelial and myocardiac cells; biological reagents for molecular biology; chemical reagents for medical use for biological processes; carriers of culture media for medical use, namely, Iscove's modified Dulbecco's medium, used for rapidly proliferating high density cell cultures; cellular function activating agents, namely,cell growth factors, hematopoietic factors, serums, namely, human and animal serums for cell culture; antibodies, namely, monoclonal antibodies for detection and treatment of pathologies; all these products being for medical use
44 Medical care and treatment; medical services for cell sampling and isolation, namely, leukapheresis medical treatment services; services for medical analysis relating to treating individuals, namely, behavior analysis for medical purposes; therapeutic treatment, namely, cell therapy for regenerative medicine
10 Medical apparatus and instruments, namely, intravascular cell reinjection catheters; apparatus for human cell culture, namely, medical device for providing human cell culture diagnosis and treatment; cell analyzers for medical treatment and diagnostic use; medical device for production of human cell grafts, namely, medical device allowing in vitro stem cell expansion for therapeutic use; instruments for cell culture, namely, medical instruments used for cell culture diagnosis and treatment; medical device for human cell selection, namely, medical device for human cell immune selection used for diagnosis and treatment
42 Research and development of new products in the field of biotechnology; services for scientific analysis for medical purposes, namely, medical research laboratory services; development of new products for medical research for third parties
The mark consists of the wording "CellProthera" in a stylized font with the letter "o" represented by a solid circle.
CELL PROTHERA
Color is not claimed as a feature of the mark.
May 30, 2022
Final Decision Transaction Processed By Ib
Oct 29, 2021
Notification Of Possible Opposition - Processed By Ib
Sep 4, 2021
Notification Processed By Ib
Aug 29, 2020
Refusal Processed By Ib
Feb 21, 2020
Notification Of Effect Of Cancellation Of Intl Reg Mailed
Feb 21, 2020
Death Of International Registration
Aug 22, 2019
Change Of Name/Address Rec'd From Ib
Aug 1, 2019
New Representative At Ib Received
Dec 14, 2018
Total Invalidation Processed By The Ib
Sep 27, 2018
Total Invalidation Of Reg Ext Protection Sent To Ib
Sep 27, 2018
Invalidation Processed
Sep 26, 2018
Total Invalidation Of Reg Ext Protection Created
Jan 26, 2018
Cancelled Section 71
May 14, 2013
Final Decision Transaction Processed By Ib
Nov 17, 2011
Final Disposition Notice Sent To Ib
Nov 17, 2011
Final Disposition Processed
Sep 21, 2011
Final Disposition Notice Created, To Be Sent To Ib
Jun 21, 2011
Registered-Principal Register
Jun 11, 2011
Notification Of Possible Opposition - Processed By Ib
May 25, 2011
Notification Of Possible Opposition Sent To Ib
May 25, 2011
Notification Of Possible Opposition Created, To Be Sent To Ib
Apr 5, 2011
Published For Opposition
Mar 17, 2011
Notification Of Possible Opposition Sent To Ib
Mar 17, 2011
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 16, 2011
Notice Of Publication
Mar 2, 2011
Law Office Publication Review Completed
Mar 2, 2011
Assigned To Lie
Feb 2, 2011
Assigned To Lie
Jan 31, 2011
Approved For Pub - Principal Register
Jan 24, 2011
Teas/Email Correspondence Entered
Jan 24, 2011
Correspondence Received In Law Office
Jan 24, 2011
Teas Request For Reconsideration Received
Aug 11, 2010
Final Refusal Mailed
Aug 10, 2010
Final Refusal Written
Aug 10, 2010
Data Modification Completed
Jul 20, 2010
Amendment From Applicant Entered
Jul 20, 2010
Correspondence Received In Law Office
Jul 17, 2010
Assigned To Lie
Jul 6, 2010
Paper Received
Jan 29, 2010
Refusal Processed By Ib
Jan 6, 2010
Non-Final Action Mailed - Refusal Sent To Ib
Jan 6, 2010
Refusal Processed By Mpu
Jan 6, 2010
Non-Final Action (Ib Refusal) Prepared For Review
Jan 5, 2010
Non-Final Action Written
Jan 2, 2010
Application Filing Receipt Mailed
Dec 29, 2009
Assigned To Examiner
Dec 29, 2009
New Application Office Supplied Data Entered In Tram
Dec 24, 2009
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
